PUBLICATIONS

Functional Subtyping with BluePrint 80-gene profile identifies 2 distinct triple positive subtypes with and without trastuzumab/chemo-sensitivity: implications for treatment from NBRST registry. Beitsch, Gittleman, Whitworth - J Clin Oncol. 2015 Oct.

Whitworth PW, Beitsch PD, Gittleman M et al. Functional subtyping with BluePrint 80-gene profile to identify distinct triple-positive subtypes with and without trastuzumab/chemosensitivity. J Clin Oncol. 2015 Oct. 33(28): 114.

Project details

Tags: Genetics, Featured

Related projects

Vivamus molestie gravida turpis